Inventor
TRAVERSE JOHN F
US20 patents
⚠️ This page may combine multiple inventors who share the name “TRAVERSE JOHN F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE CORP
17 patentsUS9221788B2Dec 29, 2015
Salts and solid forms of (S)-3-(4- (4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
CELGENE CORP21 citations92
US9629849B2Apr 25, 2017
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
CELGENE CORP7 citations84
US10463683B2Nov 5, 2019
Isotopologues of 5-azacytidine
CELGENE CORP3 citations83
US10220050B2Mar 5, 2019
Isotopologues of 5-azacytidine
CELGENE CORP3 citations83
US9309220B2Apr 12, 2016
Processes for the preparation of (S)-3-(4- (4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable forms thereof
CELGENE CORP14 citations83
US10463672B2Nov 5, 2019
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
CELGENE CORP2 citations73
US9884062B2Feb 6, 2018
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
CELGENE CORP2 citations73
US10646503B2May 12, 2020
Isotopologues of 5-azacytidine
CELGENE CORP2 citations72
US9975872B2May 22, 2018
Processes for the preparation of (s)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and pharmaceutically acceptable forms thereof
CELGENE CORP2 citations72
US12343346B2Jul 1, 2025
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
CELGENE CORP0 citations62
US11241439B2Feb 8, 2022
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
CELGENE CORP0 citations62
US12435028B2Oct 7, 2025
Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate
CELGENE CORP0 citations59
US11912644B2Feb 27, 2024
Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate
CELGENE CORP0 citations59
US11505522B2Nov 22, 2022
Processes for the preparation of (S)-tert-butyl 4,5- diamino-5-oxopentanoate
CELGENE CORP0 citations59
US9133161B2Sep 15, 2015
Processes for preparing isoindoline-1,3-dione compounds
CELGENE CORP2 citations57
US10596180B2Mar 24, 2020
Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl) oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same
CELGENE CORP0 citations52
US10717703B2Jul 21, 2020
Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate
CELGENE CORP0 citations48